Adamson spoke with Matthew Ong, a reporter with The Cancer Letter Before 2019, Blythe Adamson, a senior quantitative scientist at Flatiron Health, had never attended an annual meeting of the American Society of Clinical Oncology. In the shower, sometime in November 2018, Adamson came up with an idea for future research: “I think we should … Continue reading Q&A
This post has a summary of press coverage about results from a research study from Flatiron Health and Yale, following the Plenary Session presentation at ASCO 2019. We learned that Affordable Care Act (ACA) Medicaid expansion was associated with reduction in racial disparity in timely treatment of advanced cancer. Results were reported in the The … Continue reading Press: ACA Medicaid expansion eliminated racial disparities in timely cancer treatment
New paper in Vaccine shows staggered age targeting and the durability of protection will be key to strategic and efficient vaccination in South Africa. When an HIV vaccine is ready to launch in South Africa, an efficient implementation strategy needs to be ready. I worked with 3 women scientists in South Africa, 3 academic men … Continue reading Population targets and vaccine durability in South Africa
Want to join our book club? We’re reading the new Causal Inference Book by Miguel Hernan and James Robins. The book is forthcoming publication by Chapman & Hall/CRC and it is available for FREE right now to download from Harvard. Every few weeks my colleagues and I meet up to discuss a few chapters. We … Continue reading Causal Inference Book Club
…and learns good practices for reproducible analyses in health economics and outcomes research from software engineers. THE KEYS are functional programming, version control, style guides, and peer code review systems. READ ABOUT IT in the latest Value & Outcomes Spotlight magazine here. LEARN HANDS ON at our short-course Sat, May 18, 8am-Noon at the ISPOR … Continue reading A health economist walks into a tech company…
In this tutorial, you’ll gain access to the R code, dataset, and motivation to replicate data visualizations in my latest paper and apply the concepts to your next one. I sat on an airplane last year, flipping through The Economist, when I froze at the sight of a tiny chart littered with a mess of … Continue reading How to replicate visualization of trajectory towards UNAIDS 90-90-90 goals
The following emails are real correspondence between myself and an Associate Editor at a prestigious scientific journal, which I have called “Journal X” here. It began after I published an article in a journal with a very similar title, a “look-alike” which I am calling “Journal Y”. Names are removed for privacy. Surprise email from … Continue reading I submitted to a “look-alike” journal on purpose. This is why.
Our new study on the rise of immunotherapy drugs at the end of life with bladder cancer learned from real-world patients by using @flatironhealth curated EHR data. We hypothesized that advanced urothelial cancer patients would increasingly receive checkpoint inhibitors near the end of life, as they tend to have more favorable side effect profiles … Continue reading Immunotherapy increasing at end of life
A new comprehensive landscape analysis of Medicaid health behavior incentive programs gathers together many challenges and potential solutions in the latest issue of Health Affairs. In 2017-2018 the team interviewed 80 key-informant stakeholders and searched the literature. The most common incentive type offered by programs was gift cards or vouchers, including cash, Visa gift cards, specific venue … Continue reading Incentivizing health-promoting behaviors
There is little prior evidence of effective interventions to improve viral suppression, despite this being a critical step in the HIV care continuum as described in the National HIV/AIDS Strategy for the United States. Continue reading Should we pay some people to take their HIV drugs?